STARTUP PROFILE

Prima Mente

COUNTRY
UK
FOUNDED
2023
CATEGORY
Tools and Infrastructure
Developing biological foundation models and clinical research platforms to understand, detect, and prevent neurological disease through AI-driven neuroscience.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Software
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Dementia/impairment
TARGET USER
Pharma
REGULATORY STAGE
Investigational
Prima Mente is best understood as an AI-and-biology infrastructure company for neuroscience, seeking to build foundation-model-style systems around neurological disease understanding and intervention. Its strategic appeal depends heavily on data ownership and the defensibility of its platform rather than a single near-term product.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
12
NVIDIA and OpenAI invest in neurotech
13 October – 27 October 2026

Prima Mente was named one of five UK startups receiving minority investments from NVIDIA. Prima Mente develops AI models of the human epigenome for early Alzheimer's diagnosis. The investment amount was not disclosed; Prima Mente is still raising funds.

Articles featuring
Prima Mente
No items found.